1. Home
  2. VIVK vs NXL Comparison

VIVK vs NXL Comparison

Compare VIVK & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivakor Inc.

VIVK

Vivakor Inc.

HOLD

Current Price

$0.06

Market Cap

19.5M

Sector

Energy

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.82

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIVK
NXL
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
18.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
VIVK
NXL
Price
$0.06
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
25.6M
113.8K
Earning Date
11-19-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$125,113,426.00
$156,931.00
Revenue This Year
N/A
$38.28
Revenue Next Year
N/A
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
101.82
N/A
52 Week Low
$0.06
$0.70
52 Week High
$1.49
$4.19

Technical Indicators

Market Signals
Indicator
VIVK
NXL
Relative Strength Index (RSI) 27.38 31.12
Support Level $0.06 $0.93
Resistance Level $0.09 $1.01
Average True Range (ATR) 0.02 0.06
MACD 0.00 -0.01
Stochastic Oscillator 10.37 2.99

Price Performance

Historical Comparison
VIVK
NXL

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: